Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Epithelioid variant of gastrointestinal stromal tumor harboring PDGFRA mutation and MLH1 gene alteration: A case report.

Kobayashi M, Inaguma S, Raffeld M, Kato H, Suzuki S, Wakasugi T, Mitsui A, Kuwabara Y, Lasota J, Ikeda H, Miettinen M, Takahashi S.

Pathol Int. 2019 Jul 4. doi: 10.1111/pin.12830. [Epub ahead of print]

PMID:
31273885
2.

Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors.

Lasota J, Kowalik A, Felisiak-Golabek A, Zięba S, Waloszczyk P, Masiuk M, Wejman J, Szumilo J, Miettinen M.

Mod Pathol. 2019 Jul;32(7):957-966. doi: 10.1038/s41379-018-0163-y. Epub 2019 Feb 13.

PMID:
30760858
3.

New fusion sarcomas: histopathology and clinical significance of selected entities.

Miettinen M, Felisiak-Golabek A, Luiña Contreras A, Glod J, Kaplan RN, Killian JK, Lasota J.

Hum Pathol. 2019 Apr;86:57-65. doi: 10.1016/j.humpath.2018.12.006. Epub 2019 Jan 8.

PMID:
30633925
4.

Linking the contents of hydrophobic PAHs with the canopy water storage capacity of coniferous trees.

Anna KI, Emanuel G, Anna SR, Błońska E, Lasota J, Łagan S.

Environ Pollut. 2018 Nov;242(Pt B):1176-1184. doi: 10.1016/j.envpol.2018.08.015. Epub 2018 Aug 7.

PMID:
30118907
5.

Polycyclic Aromatic Hydrocarbons Content in Contaminated Forest Soils with Different Humus Types.

Lasota J, Błońska E.

Water Air Soil Pollut. 2018;229(6):204. doi: 10.1007/s11270-018-3857-3. Epub 2018 Jun 9.

6.

Strong disk winds traced throughout outbursts in black-hole X-ray binaries.

Tetarenko BE, Lasota JP, Heinke CO, Dubus G, Sivakoff GR.

Nature. 2018 Feb 1;554(7690):69-72. doi: 10.1038/nature25159. Epub 2018 Jan 22.

PMID:
29364880
7.

SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma.

Felisiak-Goląbek A, Inaguma S, Kowalik A, Wasąg B, Wang ZF, Zięba S, Pięciak L, Ryś J, Kopczynski J, Sarlomo-Rikala M, Góźdź S, Lasota J, Miettinen M.

Appl Immunohistochem Mol Morphol. 2018 Jan;26(1):40-45. doi: 10.1097/PAI.0000000000000500.

8.

Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression.

Inaguma S, Lasota J, Felisiak-Golabek A, Kowalik A, Wang Z, Zieba S, Kalisz J, Ikeda H, Miettinen M.

J Pathol Clin Res. 2017 Oct 7;3(4):268-278. doi: 10.1002/cjp2.81. eCollection 2017 Oct.

9.

Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.

Inaguma S, Lasota J, Wang Z, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Miettinen M.

Hum Pathol. 2018 Jan;71:1-7. doi: 10.1016/j.humpath.2017.04.032. Epub 2017 Aug 12.

10.

New Mechanisms of mTOR Pathway Activation in KIT-mutant Malignant GISTs.

Lasota J, Kowalik A, Felisiak-Golabek A, Zięba S, Wang ZF, Miettinen M.

Appl Immunohistochem Mol Morphol. 2019 Jan;27(1):54-58. doi: 10.1097/PAI.0000000000000541.

PMID:
28777148
11.

Evaluation of Brain Edema Formation Defined By MRI After LINAC-based Stereotactic Radiosurgery.

Harat M, Lebioda A, Lasota J, Makarewicz R.

Radiol Oncol. 2017 Apr 12;51(2):137-141. doi: 10.1515/raon-2017-0018. eCollection 2017 Jun.

12.

Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma.

Inaguma S, Wang Z, Lasota J, Onda M, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Pastan I, Miettinen M.

Oncotarget. 2017 Apr 18;8(16):26744-26754. doi: 10.18632/oncotarget.15814.

13.

SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma.

Lasota J, Kowalik A, Felisiak-Golabek A, Inaguma S, Wang ZF, Pięciak L, Zięba S, Pęksa R, Kopczynski J, Okoń K, Waloszczyk P, Gozdz S, Biernat W, Miettinen M.

Arch Pathol Lab Med. 2017 Apr;141(4):564-568. doi: 10.5858/arpa.2016-0147-OA. Epub 2017 Feb 28.

PMID:
28353383
14.

Application of high-resolution genomic profiling in the differential diagnosis of liposarcoma.

Koczkowska M, Lipska-Ziętkiewicz BS, Iliszko M, Ryś J, Miettinen M, Lasota J, Biernat W, Harazin-Lechowska A, Kruczak A, Limon J.

Mol Cytogenet. 2017 Mar 16;10:7. doi: 10.1186/s13039-017-0309-5. eCollection 2017.

15.

GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.

Miettinen M, Felisiak-Golabek A, Wang Z, Inaguma S, Lasota J.

Am J Surg Pathol. 2017 May;41(5):577-585. doi: 10.1097/PAS.0000000000000807.

16.

Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas.

Inaguma S, Lasota J, Wang Z, Felisiak-Golabek A, Ikeda H, Miettinen M.

Mod Pathol. 2017 Feb;30(2):278-285. doi: 10.1038/modpathol.2016.185. Epub 2016 Nov 4.

17.

Pre-resonance enhancement of exceptional intensity in Aggregation-Induced Raman Optical Activity (AIROA) spectra of lutein derivatives.

Zajac G, Lasota J, Dudek M, Kaczor A, Baranska M.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Feb 15;173:356-360. doi: 10.1016/j.saa.2016.09.030. Epub 2016 Sep 20.

PMID:
27685004
18.

Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases.

Miettinen M, Felisiak-Golabek A, Wasag B, Chmara M, Wang Z, Butzow R, Lasota J.

Am J Surg Pathol. 2016 Dec;40(12):1661-1669.

20.

Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors.

Inaguma S, Wang Z, Lasota J, Sarlomo-Rikala M, McCue PA, Ikeda H, Miettinen M.

Am J Surg Pathol. 2016 Aug;40(8):1133-42. doi: 10.1097/PAS.0000000000000653.

21.

MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases.

Kerkar SP, Wang ZF, Lasota J, Park T, Patel K, Groh E, Rosenberg SA, Miettinen MM.

J Immunother. 2016 May;39(4):181-7. doi: 10.1097/CJI.0000000000000119.

22.

Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 cases.

Lasota J, Felisiak-Golabek A, Wasag B, Kowalik A, Zięba S, Chłopek M, Wang ZF, Coates T, Kopczynski J, Gozdz S, Sarlomo-Rikala M, Miettinen M.

Mod Pathol. 2016 Mar;29(3):275-82. doi: 10.1038/modpathol.2015.160. Epub 2016 Jan 22.

23.

Influence of Oil Contamination on Physical and Biological Properties of Forest Soil After Chainsaw Use.

Klamerus-Iwan A, Błońska E, Lasota J, Kalandyk A, Waligórski P.

Water Air Soil Pollut. 2015;226(11):389. Epub 2015 Oct 31.

24.

Oncogenic Activation of the Wnt/β-Catenin Signaling Pathway in Signet Ring Stromal Cell Tumor of the Ovary.

Kopczynski J, Kowalik A, Chłopek M, Wang ZF, Góźdź S, Lasota J, Miettinen M.

Appl Immunohistochem Mol Morphol. 2016 May-Jun;24(5):e28-33. doi: 10.1097/PAI.0000000000000271.

PMID:
26509912
25.

Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.

Miettinen M, Wang Z, Lasota J, Heery C, Schlom J, Palena C.

Am J Surg Pathol. 2015 Oct;39(10):1305-12. doi: 10.1097/PAS.0000000000000462.

26.

Effect of variable soil texture, metal saturation of soil organic matter (SOM) and tree species composition on spatial distribution of SOM in forest soils in Poland.

Gruba P, Socha J, Błońska E, Lasota J.

Sci Total Environ. 2015 Jul 15;521-522:90-100. doi: 10.1016/j.scitotenv.2015.03.100. Epub 2015 Mar 30.

PMID:
25829288
27.

Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.

Miettinen M, McCue PA, Sarlomo-Rikala M, Biernat W, Czapiewski P, Kopczynski J, Thompson LD, Lasota J, Wang Z, Fetsch JF.

Am J Surg Pathol. 2015 Jun;39(6):826-35. doi: 10.1097/PAS.0000000000000398.

28.

Recurrent epimutation of SDHC in gastrointestinal stromal tumors.

Killian JK, Miettinen M, Walker RL, Wang Y, Zhu YJ, Waterfall JJ, Noyes N, Retnakumar P, Yang Z, Smith WI Jr, Killian MS, Lau CC, Pineda M, Walling J, Stevenson H, Smith C, Wang Z, Lasota J, Kim SY, Boikos SA, Helman LJ, Meltzer PS.

Sci Transl Med. 2014 Dec 24;6(268):268ra177. doi: 10.1126/scitranslmed.3009961.

PMID:
25540324
29.

Nuclear expression and gain-of-function β-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker.

Lasota J, Felisiak-Golabek A, Aly FZ, Wang ZF, Thompson LD, Miettinen M.

Mod Pathol. 2015 May;28(5):715-20. doi: 10.1038/modpathol.2014.161. Epub 2014 Nov 28.

30.

Dose estimation for different skin models in interstitial breast brachytherapy.

Lasota J, Kabacińska R, Makarewicz R.

J Contemp Brachytherapy. 2014 Jun;6(2):200-7. doi: 10.5114/jcb.2014.43167. Epub 2014 Jun 3.

31.

Intranodal palisaded myofibroblastoma: another mesenchymal neoplasm with CTNNB1 (β-catenin gene) mutations: clinicopathologic, immunohistochemical, and molecular genetic study of 18 cases.

Laskin WB, Lasota JP, Fetsch JF, Felisiak-Golabek A, Wang ZF, Miettinen M.

Am J Surg Pathol. 2015 Feb;39(2):197-205. doi: 10.1097/PAS.0000000000000299.

32.

Rare cancers.

Limon J, Miettinen M, Lasota J.

Int J Biochem Cell Biol. 2014 Aug;53:461. doi: 10.1016/j.biocel.2014.06.001. Epub 2014 Jun 4. No abstract available.

PMID:
24907398
33.

Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.

Miettinen M, Lasota J.

Int J Biochem Cell Biol. 2014 Aug;53:514-9. doi: 10.1016/j.biocel.2014.05.033. Epub 2014 Jun 2. Review.

34.

Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach.

Lasota J, Kowalik A, Wasag B, Wang ZF, Felisiak-Golabek A, Coates T, Kopczynski J, Gozdz S, Miettinen M.

Am J Surg Pathol. 2014 Sep;38(9):1235-41. doi: 10.1097/PAS.0000000000000229.

35.

Mass of a black hole firewall.

Abramowicz MA, Kluźniak W, Lasota JP.

Phys Rev Lett. 2014 Mar 7;112(9):091301. Epub 2014 Mar 3.

PMID:
24655237
36.

SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases.

Miettinen M, Wang Z, McCue PA, Sarlomo-Rikala M, Rys J, Biernat W, Lasota J, Lee YS.

Am J Surg Pathol. 2014 Mar;38(3):410-20. doi: 10.1097/PAS.0000000000000116.

37.

GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.

Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J, Wang Z.

Am J Surg Pathol. 2014 Jan;38(1):13-22. doi: 10.1097/PAS.0b013e3182a0218f.

38.

Major histocompatibility complex class II and BTNL2 associations in sarcoidosis.

Wennerström A, Pietinalho A, Lasota J, Salli K, Surakka I, Seppänen M, Selroos O, Lokki ML.

Eur Respir J. 2013 Aug;42(2):550-3. doi: 10.1183/09031936.00035213. No abstract available.

39.

No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases.

Lasota J, Xi L, Coates T, Dennis R, Evbuomwan MO, Wang ZF, Raffeld M, Miettinen M.

Mod Pathol. 2013 Nov;26(11):1488-91. doi: 10.1038/modpathol.2013.89. Epub 2013 May 24.

40.

Gastrointestinal stromal tumors.

Miettinen M, Lasota J.

Gastroenterol Clin North Am. 2013 Jun;42(2):399-415. doi: 10.1016/j.gtc.2013.01.001. Epub 2013 Mar 13. Review.

41.

Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.

Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI Jr, Jahromi MS, Xekouki P, Szarek E, Walker RL, Lasota J, Raffeld M, Klotzle B, Wang Z, Jones L, Zhu Y, Wang Y, Waterfall JJ, O'Sullivan MJ, Bibikova M, Pacak K, Stratakis C, Janeway KA, Schiffman JD, Fan JB, Helman L, Meltzer PS.

Cancer Discov. 2013 Jun;3(6):648-57. doi: 10.1158/2159-8290.CD-13-0092. Epub 2013 Apr 2.

42.

Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms.

Miettinen M, Sarlomo-Rikala M, McCue P, Czapiewski P, Langfort R, Waloszczyk P, Wazny K, Biernat W, Lasota J, Wang Z.

Appl Immunohistochem Mol Morphol. 2014 Jan;22(1):31-6. doi: 10.1097/PAI.0b013e31828bfdd3.

43.

Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.

Miettinen M, Killian JK, Wang ZF, Lasota J, Lau C, Jones L, Walker R, Pineda M, Zhu YJ, Kim SY, Helman L, Meltzer P.

Am J Surg Pathol. 2013 Feb;37(2):234-40. doi: 10.1097/PAS.0b013e3182671178.

44.
45.
46.

Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature.

Voltaggio L, Murray R, Lasota J, Miettinen M.

Hum Pathol. 2012 May;43(5):650-9. doi: 10.1016/j.humpath.2011.07.006. Epub 2011 Dec 1. Review.

47.

Histopathology of gastrointestinal stromal tumor.

Miettinen M, Lasota J.

J Surg Oncol. 2011 Dec;104(8):865-73. doi: 10.1002/jso.21945. Review.

PMID:
22069171
48.

KBA62 and PNL2: 2 new melanoma markers-immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melanomas and their mimics.

Aung PP, Sarlomo-Rikala M, Lasota J, Lai JP, Wang ZF, Miettinen M.

Am J Surg Pathol. 2012 Feb;36(2):265-72. doi: 10.1097/PAS.0b013e31823651cb.

49.

Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.

Miettinen M, Wang ZF, Sarlomo-Rikala M, Osuch C, Rutkowski P, Lasota J.

Am J Surg Pathol. 2011 Nov;35(11):1712-21. doi: 10.1097/PAS.0b013e3182260752.

Supplemental Content

Loading ...
Support Center